WIF1 Antibody

中文名稱：

WIF1兔多克隆抗體
貨號：

CSB-PA026113LA01HU
規格：

￥440
圖片：
Immunohistochemistry analysis of human testis tissue using CSB-PA026113LA01HU at dilution of 1:100

Immunocytochemistry analysis of human lung tissue using CSB-PA026113LA01HU at dilution of 1:100
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品名稱：

Rabbit anti-Homo sapiens (Human) WIF1 Polyclonal antibody
Uniprot No.：

Q9Y5W5
基因名：

WIF1
別名：

WIF-1 antibody; wif1 antibody; WIF1_HUMAN antibody; Wnt inhibitory factor 1 antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human Wnt inhibitory factor 1 protein (263-379AA)
免疫原種屬：

Homo sapiens (Human)

標記方式：

Non-conjugated

本頁面中的產品，WIF1 Antibody (CSB-PA026113LA01HU)，的標記方式是Non-conjugated。對于WIF1 Antibody，我們還提供其他標記。見下表：

標記方式	貨號	產品名稱	應用
HRP	CSB-PA026113LB01HU	WIF1 Antibody, HRP conjugated	ELISA
FITC	CSB-PA026113LC01HU	WIF1 Antibody, FITC conjugated
Biotin	CSB-PA026113LD01HU	WIF1 Antibody, Biotin conjugated	ELISA

克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
產品提供形式：

Liquid
應用范圍：

ELISA, IHC

推薦稀釋比：

Application	Recommended Dilution
IHC	1:20-1:200

Protocols：

ELISA Protocol
Immunohistochemistry (IHC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Binds to WNT proteins and inhibits their activities. May be involved in mesoderm segmentation.
基因功能參考文獻：
1. WIF1 methylation may serve as a potential prognostic marker for patients with chondrosarcoma. PMID: 28484252
2. our findings indicate that HOXC6 plays an important role in the progress and prognosis of human glioma and promotes glioma U87 cell growth through the WIF-1/Wnt signaling pathway PMID: 30228024
3. Data revealed that the upregulation of WIF1 induced autophagy in non-small cell lung cancer (NSCLC) cells. WIF1-mediated autophagy was demonstrated to inhibit Wnt/betacatenin signaling by downregulating Dvl2, which contributed to the inhibition of the proliferation and the promotion of the apoptosis of NSCLC cells. PMID: 29916529
4. WIF-1 gene methylation is associated with pathogenesis of multiple human tumors. PMID: 29970693
5. the expression of WIF-1 was low in GBC cells due to aberrant hypermethylation of its promoter region. Additionally, an alternative pathogenesis of GBC was indicated in which c-Jun causes hypermethylation of the WIF-1 promoter region, and represses the expression of WIF-1 through transcriptional regulation and interaction with DNMT1 as an early event in the tumorigenesis of GBC. PMID: 29693707
6. miR-590-3p regulates colon cancer progression via WIF1 and DKK1, which suggests that miR-590-3p may be a promising candidate for therapeutic applications in colon cancer treatment PMID: 29164578
7. We identify a loss-of-function mutation in WIF1 (NM_007191 p.W15*), which is involved in mesoderm segmentation, as the suspected cause of the Nail-Patella-like disorder observed in this family. PMID: 28383544
8. the results of our study show that down-regulated INTS6 expression is associated with a poorer prognosis in hepatocellular carcinoma (HCC) patients. This newly identified INTS6/WIF-1 axis indicates the molecular mechanism of HCC and may represent a therapeutic target in HCC patients. PMID: 28899352
9. the promoters of WIF1, NLK, and APC are highly methylated in the nasopharyngeal cancers (NPC) and gastric carcinoma (GC) cell lines, and the 3 genes are also regulated by miR-BART19-3p expressed by Epstein-Barr virus (EBV); expression of the WIF1, APC, and NLK genes is strongly affected by hypermethylation, and in EBV-associated tumors, the 3 genes are also affected by miR-BART19-3p PMID: 28543390
10. Data show the frequency of WIF-1 hypermethylation significantly increased in non-small cell lung cancer (NSCLC) specimens compared with normal lung tissue. WIF-1 hypermethylation is predominant in squamous cell carcinoma (SCC), suggesting that WIF-1 methylation contributes to the development of NSCLC, especially SCC. [review] PMID: 27911280
11. Study supported the hypothesis that Wnt inhibitory factor 1 (WIF1) is crucial as a negative regulator of the functions of endothelial cells in angiogenesis and that hypoxia plays an important role in controlling WIF1 expression and angiogenesis. PMID: 26994065
12. Our data suggests that total cellular b-catenin levels decrease in the presence of secreted frizzled-related protein 1 and Wnt inhibitory factor 1, and a significant increase in cell death after tyrosine kinase inhibitor treatment is observed. On the contrary, when secreted frizzled-related protein 1 is suppressed, total b-catenin levels increase in the cell and the cells become resistant to tyrosine kinase inhibitors. PMID: 28468589
13. Gallbladder cancer patients with hypermethylated WIF-1 exhibited worse overall survival than those with hypomethylated WIF-1. PMID: 28438695
14. In astrocytoma specimens, tumor areas with numerous single cells were identified which strongly express Wif-1. PMID: 28040794
15. Hypermethylation of WIF1 (WNT inhibitory factor 1) and NPY (neuropeptide Y) genes was significantly higher in tumor tissue compared to normal tissue, independently of tumor stage. PMID: 27251038
16. the expression levels of WIF-1 were low in gallbladder cancer tumor tissues and the GBC-SD, SGC-996 and NOZ gallbladder cancer cell lines. This low expression was associated with the methylation status of the WIF-1 gene promotor. PMID: 27430608
17. Promoter hypermethylation WIF1 play an important role in the carcinogenesis of lung cancer. PMID: 27930522
18. HOTAIR can affect the radiosensitivity of pancreatic ductal adenocarcinoma (PDAC) cells partly via regulating the expression of WIF-1, and HOTAIR-WIF-1 axis is a potential target for PDAC radiotherapy. PMID: 26482614
19. beta-catenin expression may also be a poor prognostic factor for cervical cancer (CC) while WIF1 could be a potential drug target for treatment of advanced CC. PMID: 27843945
20. Reduced expression of Wif-1 and increased expression of beta-catenin may be involved in the pathogenesis of childhood acute lymphoblastic leukemia (ALL). PMID: 27655540
21. Results provide evidence that WIF1 is frequently methylated in oral squamous cell carcinoma (OSCC), but not in oral submucous fibrosis tissues, which results in reduced expression. This epigenetic biomarker can be used for the early detection of OSCC. PMID: 26352791
22. WIF-1 down-regulation may promote tumor cells invasion and metastasis in salivary gland adenoid cystic carcinoma. PMID: 26405993
23. Loss of WIF1 enhances the migratory potential of glioblastoma through WNT5A that activates the WNT/Ca(2+) pathway and MALAT1. PMID: 25772239
24. WIF1 has a role in breast neoplasms: its inhibition significantly relieves the cancer stem cell-limiting effects of dietary compound isoliquiritigenin PMID: 25918249
25. Data show that the WIF domain of Wnt Inhibitory Factor 1 (WIF1) is bound by C-terminal domains of Wnt proteins Wnt5a and Wnt7a at two sites. PMID: 26342861
26. detection of methylated Wif-1 in either S or U has a higher performance accuracy compared to guaiac FOBT for advanced colorectal neoplasia screening PMID: 25025467
27. miR-603 regulates glioma development via Wnt-beta-cateninn signaling pathway and its WIF1 and CTNNBIP1 targets. PMID: 25681036
28. Further evaluation of the methylation of DACH1, DKK1, and WIF1 in a clinical patient group confirmed the frequent methylation of WIF1 and intermediate or low frequency of methylation of DACH1 or DKK1, respectively. PMID: 25487617
29. Altered expression of genes associated with telomere maintenance and cell function of human vascular endothelial cell at elevated temperature. PMID: 25142166
30. Aberrant methylation of APC gene was statistically significant associated with age over 50, DDK3 with male, SFRP4, WIF1, and WNT5a with increasing tumor stage SFRP4 and WIF1 with tumor differentiation and SFRP2 and SFRP5 with histological type PMID: 25107489
31. Coexpression of SFRP1 and WIF1, rather than SFRP1 or WIF1 alone, could be used, together with low TNM stage, as a prognostic predictor of favorable outcomes in CRC. PMID: 24949429
32. MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1. PMID: 24755295
33. WIF-1 is frequently methylated and that Wnt5a acts as a tumor suppressor gene in colorectal carcinoma. PMID: 24833087
34. genetic alterations of beta-catenin and epigenetics-related Wif-1 promoter hypermethylation may be important mechanisms underlying adrenocortical tumor formation PMID: 24755523
35. WIF1 downregulation is a frequent event in salivary gland carcinoma ex-pleomorphic adenoma. PMID: 24853424
36. melanocytes express WIF-1 constitutively in vivo and in vitro and that WIF-1 promotes melanogenesis in normal human melanocytes. PMID: 24131586
37. WIF-1 is downregulated and functions as a tumor suppressor by antagonizing Wnt/beta-catenin signaling in neuroblastoma. PMID: 24561119
38. Wif1 methylation showed an association with unfavorable prognosis of adenocarcinoma (AC) patients with EGFR mutation. PMID: 23686431
39. Promoter methylation of WIF1, PENK and NPY is associated with colorectal adenocarcinoma (CRC) diagnosis and can be used to CRC from other cancers. PMID: 24289328
40. HOTAIR directly decreased WIF-1 expression by promoting its histone H3K27 methylation in the promoter region and then activated the Wnt/beta-catenin signaling pathway. PMID: 24118380
41. Significantly higher methylation was observed in genes NTKR1, GATA4 and WIF1 in the ovarian cancer group compared with the control group. PMID: 23746174
42. WIF1 expression is downregulated by promoter methylation and is an important mechanism of aberrant WNT/beta-catenin pathway activation in astrocytoma pathogenesis PMID: 23328978
43. The miR-29 family (miR-29a, -29b, and -29c) suppresses the Wnt signaling pathway through demethylation of WIF-1 in non-small-cell lung cancer. PMID: 23939044
44. These in vivo data support the involvement of Wnt signaling in the development of aortic stenosis and suggest that circulating Wnt modulators such as WIF1 should be further investigated as risk markers in larger aortic stenosis populations. PMID: 23316316
45. WIF1 is a marker of interfollicular keratinocyte stem cells and inhibits their cell cycle progression even with Wnt3 signaling. PMID: 23358094
46. Loss of WIF-1 expression due to methylation is related to aggressiveness of sporadic breast cancer. PMID: 23417837
47. It was shown that WIF-1 downregulation is involved in melasma development due to the stimulation of melanogenesis and melanosome transfer through upregulation of the canonical and the noncanonical Wnt signaling pathway. PMID: 22951732
48. This study demonistrated that Wnt inhibitory factor-1 regulates glioblastoma cell cycle and proliferation. PMID: 22901505
49. Epigenetic inactivation of Wnt inhibitory factor-1 is associated with esophageal squamous cell carcinoma. PMID: 23193918
50. A Wnt-binding site of the WIF-domain of WIF1 was localized. Substitution of some residues of WIF resulted in an increased affinity for Wnt5a, but decreased affinity for Wnt3a, suggesting that these residues may define the specificity of WIF for Wnts. PMID: 22986341
顯示更多

收起更多
亞細胞定位：

Secreted.
數據庫鏈接：

HGNC: 18081

OMIM: 605186

KEGG: hsa:11197

STRING: 9606.ENSP00000286574

UniGene: Hs.284122

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human
VDR Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human